Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease
暂无分享,去创建一个
Bruno Vellas | David Ames | Howard Feldman | Serge Gauthier | Birol Emir | H. Feldman | S. Gauthier | B. Vellas | D. Ames | J. Hecker | B. Emir | E. Whalen | Jane Hecker | Ponni Subbiah | Edward Whalen | P. Subbiah
[1] B L Miller,et al. Cerebral blood flow correlates of apathy in Alzheimer disease. , 1996, Archives of neurology.
[2] John R. Williams. DECLARATION OF HELSINKI , 1964 .
[3] J. Duffy. The Neural Substrates of Motivation , 1997 .
[4] L. Teri,et al. Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver distress. , 1997, Alzheimer disease and associated disorders.
[5] A. Kurz,et al. A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.
[6] J. Cohen-Mansfield,et al. Relationship between depression and agitation in nursing home residents. , 1988, Comprehensive gerontology. Section B, Behavioural, social, and applied sciences.
[7] J. Cummings,et al. Effect of Tacrine on Behavioral Symptoms in Alzheimer's Disease: An Open-Label Study , 1996, Journal of geriatric psychiatry and neurology.
[8] R. Loewenson,et al. Predictors of nursing home placement of patients with Alzheimer's disease. , 1985, Texas medicine.
[9] P. Tariot,et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD , 2000, Neurology.
[10] M. Mega,et al. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. , 1999, Archives of neurology.
[11] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[12] Jeffrey L. Cummings,et al. The spectrum of behavioral changes in Alzheimer's disease , 1996, Neurology.
[13] B. Gulanski,et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease , 1998, Neurology.
[14] R. Mohs,et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients , 2001, Neurology.
[15] H. Feldman,et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease , 2001, Neurology.
[16] C. Ballard,et al. Neuropsychiatric aspects of alzheimer’s disease , 1999, Current psychiatry reports.
[17] B. Winblad,et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.
[18] D. Coakley,et al. BEHAVIOUR DISTURBANCE AND OTHER PREDICTORS OF CARER BURDEN IN ALZHEIMER'S DISEASE , 1997, International journal of geriatric psychiatry.
[19] J. Cummings,et al. The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease. , 1998, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[20] N. Herrmann,et al. Donepezil for behavioural disorders associated with Lewy bodies: a case series , 2000, International journal of geriatric psychiatry.
[21] R. Bartus,et al. The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.
[22] S. Starkstein,et al. Neuropsychological correlates of apathy and depression in patients with dementia , 1999, Neurology.
[23] H.-J. Möller,et al. The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.
[24] C. Fairburn,et al. Natural history of aggressive behaviour in dementia , 1999, International journal of geriatric psychiatry.
[25] R. Marin,et al. Apathy: Concept, Syndrome, Neural Mechanisms, and Treatment. , 1996, Seminars in clinical neuropsychiatry.
[26] M. Albert,et al. The course of psychopathologic features in mild to moderate Alzheimer disease. , 1997, Archives of general psychiatry.
[27] B. Miller,et al. Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. , 1996, The American journal of psychiatry.
[28] E. Perry,et al. Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type , 1990 .
[29] B. Reisberg,et al. Functional Assessment Staging (FAST) in Alzheimer's Disease: Reliability, Validity, and Ordinality , 1992, International Psychogeriatrics.
[30] Murat Emre,et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.
[31] T Hope,et al. Predictors of institutionalization for people with dementia living at home with a carer , 1998, International journal of geriatric psychiatry.
[32] H. Sackeim,et al. Behavioral Syndromes in Alzheimer's Disease , 1992, International Psychogeriatrics.
[33] J. Cummings,et al. The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. , 1995, The Journal of neuropsychiatry and clinical neurosciences.